| Reducing risk of renal failure in obese patients - EurekAlert (press release) |
|
|
EurekAlert (press release) The angiotensin-converting enzyme (ACE) inhibitor drug, ramipril, is particularly effective in lowering the risk of end-stage renal disease (ESRD) in obese patients, according to a study appearing in an upcoming issue of the Journal of the American |